Boothbay Fund Management, LLC Fate Therapeutics Inc Put Options Transaction History

Boothbay Fund Management, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $483,184 - $649,834	-10,100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $88,905 - $143,595	-1,500 Reduced 12.93%	10,100 $599,000
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $780,100 - $1.07 Million	11,600 New	11,600 $1.01 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.